Inventor · disambiguated record
Hermann Gram
Also filed as: GRAM HERMANN
20 granted patents·16 pending applications·274 citations·filing 1996–2024
95Inventor score
Top patents by PatentIndex Score
36 records- 0196US7807155B2IL-17 antagonistic antibodiesNOVARTIS AG·Filed 2005·Granted Oct 5, 2010·72 cites·22 claims
- 0295US7446175B2Antibodies to human IL-1βNOVARTIS AG·Filed 2001·Granted Nov 4, 2008·72 cites·7 claims
- 0394US8119131B2IL-17 antagonistic antibodiesDI PADOVA FRANCO E·Filed 2010·Granted Feb 21, 2012·42 cites·23 claims
- 0491US8617552B2IL-17 antibodiesDI PADOVA FRANCO E·Filed 2012·Granted Dec 31, 2013·14 cites·10 claims
- 0591US7491392B2Antibodies to human IL-1βNOVARTIS AG·Filed 2006·Granted Feb 17, 2009·13 cites·13 claims
- 0690US8273350B2Antibodies to human IL-1βGRAM HERMANN·Filed 2011·Granted Sep 25, 2012·14 cites·14 claims
- 0789US2025122277A1Interleukin-17 (il-17) antagonistic antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0887US7993878B2Antibodies to human IL-1βNOVARTIS AG·Filed 2008·Granted Aug 9, 2011·8 cites·14 claims
- 0982US2023235038A1Interleukin-17 (il-17) antagonistic antibodiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1082US2024083997A1Methods of Using IL-1beta CompoundsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1181US8524667B2Methods of treating gout using IL-1BETA antibodiesGRAM HERMANN·Filed 2012·Granted Sep 3, 2013·3 cites·22 claims
- 1278US10106604B2Method of treating auto-inflammatory syndromes with IL-1beta antibodies related to canakinumabNOVARTIS AG·Filed 2016·Granted Oct 23, 2018·1 cites·18 claims
- 1376US2021179705A1Methods of treating auto-inflammatory syndromes using il-1beta antibodiesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1471US10968272B2Methods of treating a crystal induced arthropathy using IL-1beta antibodiesNOVARTIS AG·Filed 2018·Granted Apr 6, 2021·0 cites·12 claims
- 1570US2021147533A1Methods of Using IL-1beta CompoundsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1669US2019270804A1Il-17 antagonistic antibodiesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1768US8409576B2Use of IL-1beta compoundsLOWE PHIL·Filed 2011·Granted Apr 2, 2013·1 cites·10 claims
- 1866US10344084B2IL-17 antagonistic antibodiesNOVARTIS AG·Filed 2017·Granted Jul 9, 2019·0 cites·17 claims
- 1966US8282922B2Method of treating an auto-inflammatory syndrome with a human IL-1β binding antibodyGRAM HERMANN·Filed 2008·Granted Oct 9, 2012·0 cites·9 claims
- 2065US2009232803A1Antibodies to human il-1betaGRAM HERMANN·Filed 2009·Application pending·0 cites
- 2164US9168298B2Methods of treating vascular disease using an IL-1beta AntibodyGRAM HERMANN·Filed 2013·Granted Oct 27, 2015·0 cites·12 claims
- 2264US2018201674A1Methods of Using IL-1beta CompoundsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2363US2014079719A1IL-17 Antagonistic AntibodiesDI PADOVA FRANCO E·Filed 2013·Application pending·0 cites
- 2461US2017218063A1Methods of Using IL-1beta CompoundsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2560US9534047B2Methods of treating Kawasaki disease using IL-1beta antibodiesGRAM HERMANN·Filed 2015·Granted Jan 3, 2017·0 cites·11 claims
- 2659US9765140B2IL-17 antagonistic antibodiesNOVARTIS AG·Filed 2015·Granted Sep 19, 2017·0 cites·3 claims
- 2759US2013171167A1Methods of Using IL-1beta CompoundsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 2857US8105587B2Methods of treating arthritis using IL-1β binding moleculesLOWE PHIL·Filed 2006·Granted Jan 31, 2012·0 cites·6 claims
- 2953US9649377B2Methods of using IL-1β compounds to treat familial mediterranean fever (FMF)LOWE PHILIP·Filed 2015·Granted May 16, 2017·0 cites·11 claims
- 3053US6423512B1Fusion polypeptidesNOVARTIS AG·Filed 1997·Granted Jul 23, 2002·17 cites·13 claims
- 3153US2011182894A1Methods of treating diabetes using IL-1beta antibodiesGRAM HERMANN·Filed 2011·Application pending·0 cites
- 3252US2008318838A1PeptidesBAUER WILFRIED·Filed 2008·Application pending·0 cites
- 3350US5858728AMonoclonal antibody against LPS coreCOMMON SERVICES AGENCY·Filed 1996·Granted Jan 12, 1999·17 cites·26 claims
- 3450US2003124617A1Antibodies to human il 1-betaFiled 2001·Application pending·0 cites
- 3546US2005009147A1PeptidesFiled 2004·Application pending·0 cites
- 3637US2002132823A1Assay methodFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →